These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38906700

  • 1. Investigating the Correlation between Genotypes and Hepatic Protein Expression of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 Using Postmortem Tissue from a Danish Population.
    Pedersen KW, Andersen JD, Hansen J, Børsting C, Banner J, Hasselstrøm JB, Jornil JR.
    Drug Metab Dispos; 2024 Aug 14; 52(9):975-980. PubMed ID: 38906700
    [Abstract] [Full Text] [Related]

  • 2. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW, Wangchuk S, Boonprasert K, Tarasuk M, Na-Bangchang K.
    Drug Metab Pers Ther; 2019 Dec 18; 34(4):. PubMed ID: 32004143
    [Abstract] [Full Text] [Related]

  • 3. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
    Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, Manolopoulos VG.
    Fundam Clin Pharmacol; 2007 Aug 18; 21(4):419-26. PubMed ID: 17635181
    [Abstract] [Full Text] [Related]

  • 4. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population.
    Céspedes-Garro C, Rodrigues-Soares F, Jiménez-Arce G, Naranjo MG, Tarazona-Santos E, Fariñas H, Barrantes R, Llerena A, CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics & Pharmacogenomics RIBEF.
    Rev Biol Trop; 2016 Sep 18; 64(3):1067-76. PubMed ID: 29461783
    [Abstract] [Full Text] [Related]

  • 5. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I, Stojković O.
    Int J Legal Med; 2020 Mar 18; 134(2):433-439. PubMed ID: 31858263
    [Abstract] [Full Text] [Related]

  • 6. Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors.
    Zhu L, Liao S, Wang N, Ge T, Yang J, Xu G, Wang J, Li K, Li G.
    Int J Clin Pharmacol Ther; 2016 Aug 18; 54(8):587-96. PubMed ID: 27191765
    [Abstract] [Full Text] [Related]

  • 7. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG, Rodrigues-Soares F, Peñas-Lledó EM, Tarazona-Santos E, Fariñas H, Rodeiro I, Terán E, Grazina M, Moya GE, López-López M, Sarmiento AP, Calzadilla LR, Ramírez-Roa R, Ortiz-López R, Estévez-Carrizo FE, Sosa-Macías M, Barrantes R, LLerena A, CEIBA-Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF.
    OMICS; 2018 Sep 18; 22(9):575-588. PubMed ID: 30183544
    [Abstract] [Full Text] [Related]

  • 8. Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.
    Ota T, Kamada Y, Hayashida M, Iwao-Koizumi K, Murata S, Kinoshita K.
    Int J Med Sci; 2015 Sep 18; 12(1):78-82. PubMed ID: 25552922
    [Abstract] [Full Text] [Related]

  • 9. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
    Veiga MI, Asimus S, Ferreira PE, Martins JP, Cavaco I, Ribeiro V, Hai TN, Petzold MG, Björkman A, Ashton M, Gil JP.
    Eur J Clin Pharmacol; 2009 Apr 18; 65(4):355-63. PubMed ID: 18979093
    [Abstract] [Full Text] [Related]

  • 10. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
    Powers JL, Buys SS, Fletcher D, Melis R, Johnson-Davis KL, Lyon E, Malmberg EM, McMillin GA.
    J Clin Pharmacol; 2016 Dec 18; 56(12):1570-1581. PubMed ID: 27198207
    [Abstract] [Full Text] [Related]

  • 11. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG, Caputi AP, D'Arrigo C, Fava G, Spina E.
    Pharmacol Res; 2004 Aug 18; 50(2):195-200. PubMed ID: 15177309
    [Abstract] [Full Text] [Related]

  • 12. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review.
    Dorji PW, Tshering G, Na-Bangchang K.
    J Clin Pharm Ther; 2019 Aug 18; 44(4):508-524. PubMed ID: 30980418
    [Abstract] [Full Text] [Related]

  • 13. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F, Sosa-Macías M, Ramos BPL, Naranjo MG, LLerena A.
    OMICS; 2017 Sep 18; 21(9):509-519. PubMed ID: 28873029
    [Abstract] [Full Text] [Related]

  • 14. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
    Yousef AM, Bulatova NR, Newman W, Hakooz N, Ismail S, Qusa H, Zahran F, Anwar Ababneh N, Hasan F, Zaloom I, Khayat G, Al-Zmili R, Naffa R, Al-Diab O.
    Mol Biol Rep; 2012 Oct 18; 39(10):9423-33. PubMed ID: 22722998
    [Abstract] [Full Text] [Related]

  • 15. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.
    Naujokaitis D, Asmoniene V, Kadusevicius E.
    Medicine (Baltimore); 2021 Mar 19; 100(11):e24545. PubMed ID: 33725937
    [Abstract] [Full Text] [Related]

  • 16. Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.
    Dong Y, Xiao H, Wang Q, Zhang C, Liu X, Yao N, Sheng H, Li H.
    Int J Clin Exp Med; 2015 Mar 19; 8(10):18917-26. PubMed ID: 26770516
    [Abstract] [Full Text] [Related]

  • 17. Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study.
    Ju S, Gao Y, Cao X, Zhang XF, Yan CC, Liu FT.
    Genet Test Mol Biomarkers; 2017 Sep 19; 21(9):539-546. PubMed ID: 28872889
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population.
    Krasniqi V, Dimovski A, Bytyqi HQ, Eftimov A, Šimičević L, Božina N.
    Arh Hig Rada Toksikol; 2017 Sep 26; 68(3):180-184. PubMed ID: 28976882
    [Abstract] [Full Text] [Related]

  • 19. Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.
    Fohner A, Muzquiz LI, Austin MA, Gaedigk A, Gordon A, Thornton T, Rieder MJ, Pershouse MA, Putnam EA, Howlett K, Beatty P, Thummel KE, Woodahl EL.
    Pharmacogenet Genomics; 2013 Aug 26; 23(8):403-14. PubMed ID: 23778323
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.